Report Detail
Global Hemostatic Agents Market Growth 2019-2024
- RnM3064698 |
- 06 March, 2019 |
- Global |
- 167 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
According to this study, over the next five years the Hemostatic Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemostatic Agents business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Agents market by product type, application, key manufacturers and key regions and countries.
This study considers the Hemostatic Agents value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Surgical Centers
Nursing Homes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hemostatic Agents consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemostatic Agents market by identifying its various subsegments.
Focuses on the key global Hemostatic Agents manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemostatic Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemostatic Agents submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Hemostatic Agents Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hemostatic Agents Consumption 2014-2024
- 2.1.2 Hemostatic Agents Consumption CAGR by Region
- 2.2 Hemostatic Agents Segment by Type
- 2.2.1 Gelation Sponge
- 2.2.2 Oxidized Regenerated Cellulose Based Hemostats
- 2.2.3 Others
- 2.3 Hemostatic Agents Consumption by Type
- 2.3.1 Global Hemostatic Agents Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Hemostatic Agents Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Hemostatic Agents Sale Price by Type (2014-2019)
- 2.4 Hemostatic Agents Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Surgical Centers
- 2.4.3 Nursing Homes
- 2.5 Hemostatic Agents Consumption by Application
- 2.5.1 Global Hemostatic Agents Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Hemostatic Agents Value and Market Share by Application (2014-2019)
- 2.5.3 Global Hemostatic Agents Sale Price by Application (2014-2019)
3 Global Hemostatic Agents by Players
- 3.1 Global Hemostatic Agents Sales Market Share by Players
- 3.1.1 Global Hemostatic Agents Sales by Players (2017-2019)
- 3.1.2 Global Hemostatic Agents Sales Market Share by Players (2017-2019)
- 3.2 Global Hemostatic Agents Revenue Market Share by Players
- 3.2.1 Global Hemostatic Agents Revenue by Players (2017-2019)
- 3.2.2 Global Hemostatic Agents Revenue Market Share by Players (2017-2019)
- 3.3 Global Hemostatic Agents Sale Price by Players
- 3.4 Global Hemostatic Agents Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Hemostatic Agents Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Hemostatic Agents Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Hemostatic Agents by Regions
- 4.1 Hemostatic Agents by Regions
- 4.1.1 Global Hemostatic Agents Consumption by Regions
- 4.1.2 Global Hemostatic Agents Value by Regions
- 4.2 Americas Hemostatic Agents Consumption Growth
- 4.3 APAC Hemostatic Agents Consumption Growth
- 4.4 Europe Hemostatic Agents Consumption Growth
- 4.5 Middle East & Africa Hemostatic Agents Consumption Growth
5 Americas
- 5.1 Americas Hemostatic Agents Consumption by Countries
- 5.1.1 Americas Hemostatic Agents Consumption by Countries (2014-2019)
- 5.1.2 Americas Hemostatic Agents Value by Countries (2014-2019)
- 5.2 Americas Hemostatic Agents Consumption by Type
- 5.3 Americas Hemostatic Agents Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Hemostatic Agents Consumption by Countries
- 6.1.1 APAC Hemostatic Agents Consumption by Countries (2014-2019)
- 6.1.2 APAC Hemostatic Agents Value by Countries (2014-2019)
- 6.2 APAC Hemostatic Agents Consumption by Type
- 6.3 APAC Hemostatic Agents Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Hemostatic Agents by Countries
- 7.1.1 Europe Hemostatic Agents Consumption by Countries (2014-2019)
- 7.1.2 Europe Hemostatic Agents Value by Countries (2014-2019)
- 7.2 Europe Hemostatic Agents Consumption by Type
- 7.3 Europe Hemostatic Agents Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Hemostatic Agents by Countries
- 8.1.1 Middle East & Africa Hemostatic Agents Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Hemostatic Agents Value by Countries (2014-2019)
- 8.2 Middle East & Africa Hemostatic Agents Consumption by Type
- 8.3 Middle East & Africa Hemostatic Agents Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Hemostatic Agents Distributors
- 10.3 Hemostatic Agents Customer
11 Global Hemostatic Agents Market Forecast
- 11.1 Global Hemostatic Agents Consumption Forecast (2019-2024)
- 11.2 Global Hemostatic Agents Forecast by Regions
- 11.2.1 Global Hemostatic Agents Forecast by Regions (2019-2024)
- 11.2.2 Global Hemostatic Agents Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Hemostatic Agents Forecast by Type
- 11.8 Global Hemostatic Agents Forecast by Application
12 Key Players Analysis
- 12.1 Ethicon
- 12.1.1 Company Details
- 12.1.2 Hemostatic Agents Product Offered
- 12.1.3 Ethicon Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Ethicon News
- 12.2 Pfizer
- 12.2.1 Company Details
- 12.2.2 Hemostatic Agents Product Offered
- 12.2.3 Pfizer Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Pfizer News
- 12.3 Baxter International
- 12.3.1 Company Details
- 12.3.2 Hemostatic Agents Product Offered
- 12.3.3 Baxter International Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Baxter International News
- 12.4 C. R. Bard
- 12.4.1 Company Details
- 12.4.2 Hemostatic Agents Product Offered
- 12.4.3 C. R. Bard Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 C. R. Bard News
- 12.5 The Medicines Company
- 12.5.1 Company Details
- 12.5.2 Hemostatic Agents Product Offered
- 12.5.3 The Medicines Company Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 The Medicines Company News
- 12.6 Anika Therapeutics
- 12.6.1 Company Details
- 12.6.2 Hemostatic Agents Product Offered
- 12.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Anika Therapeutics News
- 12.7 Advanced Medical Solutions
- 12.7.1 Company Details
- 12.7.2 Hemostatic Agents Product Offered
- 12.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Advanced Medical Solutions News
- 12.8 Integra LifeSciences
- 12.8.1 Company Details
- 12.8.2 Hemostatic Agents Product Offered
- 12.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Integra LifeSciences News
- 12.9 B Braun Melsungen
- 12.9.1 Company Details
- 12.9.2 Hemostatic Agents Product Offered
- 12.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 B Braun Melsungen News
- 12.10 Gelita Medical
- 12.10.1 Company Details
- 12.10.2 Hemostatic Agents Product Offered
- 12.10.3 Gelita Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Gelita Medical News
- 12.11 Equimedical
- 12.12 Vascular Solutions
- 12.13 Marine Polymer Technologies
- 12.14 Z-Medica
- 12.15 CryoLife
- 12.16 BioCer Entwicklungs
- 12.17 Biom’Up SAS
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hemostatic Agents . Industry analysis & Market Report on Hemostatic Agents is a syndicated market report, published as Global Hemostatic Agents Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Hemostatic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
